The University of Southampton
University of Southampton Institutional Repository

Reduction of interobserver variability (IOV) by FDG-PET–based tumor volume delineation (TVD) in radiotherapy planning for pancreatic cancer.

Reduction of interobserver variability (IOV) by FDG-PET–based tumor volume delineation (TVD) in radiotherapy planning for pancreatic cancer.
Reduction of interobserver variability (IOV) by FDG-PET–based tumor volume delineation (TVD) in radiotherapy planning for pancreatic cancer.
Background: wide IOV has been reported for CT-based TVD during radiotherapy planning for pancreatic cancer (Yamazaki, Anticancer Research 27: 2965-2972, 2007). PET-CT has been successfully incorporated into treatment planning in other tumour sites and has been shown to reduce IOV, but no study has looked at its role in pancreatic radiotherapy.

Methods: six radiation oncologists from 6 oncology centers in the UK were asked to outline GTVs in two cases with pancreatic head tumors. DICOM data set of planning CT, diagnostic CT and FDG-PET-CT scans were made available. GTV was first outlined using the information on the diagnostic CT scan alone, without access to PET scans (GTV_CT). The GTVs were then re-outlined using additional information from the PET scan (GTV_PET). A PTV was grown from the GTV, using a margin of 2cm sup-inf and 1.5cm radially from the GTV, as per standard UK practice.

Results: a total of 48 countours (24 GTV contours and 24 PTV contours) were analysed, and the results are presented below (Table).

Conclusions: the incorporation of PET scan resulted in a prominent reduction in standard deviation around tumor volumes, smaller largest:smallest GTV ratios and a larger percentage of overlap between investigator volumes, suggesting a reduction in Inter-Observer Variability. PET based RT planning should be considered in multicenter radiotherapy trials in pancreatic cancer to reduce IOV.
1527-7755
Branagan, Jennifer Mary Rose
ab533cce-c744-4e07-ab30-623238bc6485
Halle, Charlotte
02f4c653-dfc0-42d2-90e8-22605494e233
Falk, Stephen
6bda4f5d-d5b0-4558-89d3-9e32cacf202a
Hurt, Chris
bf8b37a0-8f08-4b47-b3f3-6fc65f7ab87f
et al.
Branagan, Jennifer Mary Rose
ab533cce-c744-4e07-ab30-623238bc6485
Halle, Charlotte
02f4c653-dfc0-42d2-90e8-22605494e233
Falk, Stephen
6bda4f5d-d5b0-4558-89d3-9e32cacf202a
Hurt, Chris
bf8b37a0-8f08-4b47-b3f3-6fc65f7ab87f

Branagan, Jennifer Mary Rose, Halle, Charlotte and Falk, Stephen , et al. (2013) Reduction of interobserver variability (IOV) by FDG-PET–based tumor volume delineation (TVD) in radiotherapy planning for pancreatic cancer. Journal of Clinical Oncology, 31 (4_suppl). (doi:10.1200/jco.2013.31.4_suppl.229).

Record type: Article

Abstract

Background: wide IOV has been reported for CT-based TVD during radiotherapy planning for pancreatic cancer (Yamazaki, Anticancer Research 27: 2965-2972, 2007). PET-CT has been successfully incorporated into treatment planning in other tumour sites and has been shown to reduce IOV, but no study has looked at its role in pancreatic radiotherapy.

Methods: six radiation oncologists from 6 oncology centers in the UK were asked to outline GTVs in two cases with pancreatic head tumors. DICOM data set of planning CT, diagnostic CT and FDG-PET-CT scans were made available. GTV was first outlined using the information on the diagnostic CT scan alone, without access to PET scans (GTV_CT). The GTVs were then re-outlined using additional information from the PET scan (GTV_PET). A PTV was grown from the GTV, using a margin of 2cm sup-inf and 1.5cm radially from the GTV, as per standard UK practice.

Results: a total of 48 countours (24 GTV contours and 24 PTV contours) were analysed, and the results are presented below (Table).

Conclusions: the incorporation of PET scan resulted in a prominent reduction in standard deviation around tumor volumes, smaller largest:smallest GTV ratios and a larger percentage of overlap between investigator volumes, suggesting a reduction in Inter-Observer Variability. PET based RT planning should be considered in multicenter radiotherapy trials in pancreatic cancer to reduce IOV.

This record has no associated files available for download.

More information

Published date: February 2013

Identifiers

Local EPrints ID: 488115
URI: http://eprints.soton.ac.uk/id/eprint/488115
ISSN: 1527-7755
PURE UUID: b68786aa-8f5b-443b-8449-85340de87a36
ORCID for Chris Hurt: ORCID iD orcid.org/0000-0003-1206-8355

Catalogue record

Date deposited: 15 Mar 2024 18:01
Last modified: 23 Mar 2024 03:13

Export record

Altmetrics

Contributors

Author: Jennifer Mary Rose Branagan
Author: Charlotte Halle
Author: Stephen Falk
Author: Chris Hurt ORCID iD
Corporate Author: et al.

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×